Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by xena555on Jun 11, 2019 9:48am

118 Views

Post# 29814843

another name in the NMIBC space

I'm not sure if this has already been covered on this board, but those with an interest in TLT should be aware of Sesen (SESN.Q). They just had their pre-BLA meeting with the FDA for their treatment of non-muscle invasive bladder cancer.
I believe TLT''s clinical data is superior to that of SESN.

Bullboard Posts

Visionstate set to leverage success in the U.S. market